ABSTRACI Seven workers exposed to ultraviolet printing inks developed contact dermatitis. Six cases were allergic and one irritant. A urethane acrylate resin accounted for five cases of sensitisation, one of which was also sensitive to pentaerythritol triacrylate and another also to an epoxy acrylate resin. One instance of allergy to trimethylpropane triacrylate accounted for the sixth case of contact dermatitis in this group of workers. An irritant reaction is presumed to account for the dermatitis in the individual not proved to have cutaneous allergy by patch tests. In this instance trimethylpropane triacrylate was thought to be the most likely irritating agent. Laboratory investigation proved urethane acrylate to be an allergen. The results of investigations of the sensitisation potentials of urethane acrylate, methylmethacrylate, epoxy acrylate resins, toluene-2,4-diisocyanate, and other multifunctional acrylic monomers in the albino guinea pig are presented. The interpretation of such predictive tests is discussed.
Inks and coatings based on acrylated resins, reactive low molecular weight acrylates, and light absorbing chemicals have established specific uses in industry in the last decade. ' These materials have not becotfne as widely used as was originally expected2 due to the cost of raw materials and health problems, principally cutaneous disease, that have arisen in workers manufacturing them3-5 and using the finished products containing them. [6] [7] [8] Binding of acrylated oligomer such as acrylated alkyds, acrylated epoxy resins (EAs), polyester acrylates, or coating. As the low molecular weight acrylate is of low viscosity, it may often be used as a diluent for the other system components rather than a hydrocarbon solvent, as has been the case in conventional inks and coatings. This offers the advantage that almost no loss of coating thickness occurs with drying as the diluent is bound up in the final cured or dried material rather than evaporating as in conventional systems. This feature has great usefulness in certain applications-for instance, in coating systems to prevent dental caries where the dental coating applied in this fashion dries without leaving any breaks that might allow passage of bacteria into the coated tooth. 3 Nethercott, Jakubovic, Pilger, and Smith CH2 =CH-CO-CH2 -CH2 -CH2 -CH2 -CH2 -CH2 -0-C-CH=CH2 In case 1 a 2 mm punch biopsy of the skin was taken from the centre of the urethane acrylate patch test site shortly after the 48 hour visual scoring procedure. The skin biopsy specimen was fixed in formalin and processed for light microscopic examination using haematoxylin-phloxine-saffron staining. Company) covered with a three-inch (7.6 cm) elastic adhesive bandage wrapped firmly about the animals. The bandages were removed 48 hours after they were applied.
RESULTS
Challenge testing All animals were challenged two weeks after topical exposure. A 5 cm x 5 cm area of the flank was clipped and then shaved with care to avoid abrading the skin. The challenge concentrations were nonirritant concentrations that had been determined in control animals as described above. The patches were applied as described above to assess irritancy. After 24 hours the patches were removed. The sites were examined at 48 hours for evidence of reaction; no endeavour was made to score the intensity of the reaction. Table 3 notes the proportion of animals exhibiting reactions. Probit analysis was carried out using logprobability paper to calculate the intradermal (ID) concentration required to sensitise half the guineapigs (IDSC50), except for TDI, which was tested at only one concentration. ' Allergic contact dermatitis due to urethane acrylate in ultraviolet cured inks Method The method described by Draize and associates '6 was used. After shaving the lower back of the rabbits, 0-5 ml of 100% urethane acrylate was applied to the skin to an abraded and non-abraded site of 2 cm x 2 cm. The two sites were occluded with sterile 2 cm x 2 cm gauze squares that were in turn held in place with an elastic adhesive bandage. The occlusive bandages and gauze were removed after 24 hours, and the sites were examined at 48 hours after application for evidence of cutaneous reaction. Reactions were scored using the standard method. ' 

Comment
The cutaneous disease of the seven affected workers was characteristic of contact dermatitis, based on the distribution and character of the lesions and the time course of the eruptions, all of which support the diagnosis. Historical data elicited from the workers confirmed a relation to work.
It is well recognised that the light sensitive inks to which these workers were exposed possess components with both irritant and allergic properties.' [3] [4] [5] [6] [7] [8] Initial investigation in case 1 suggested that PETA was the culprit, but when it was discpvered that it was not in the ink formulations in use at that time in the plant further investigation was undertaken. This led to the discovery of positive epicutaneous tests to urethane acrylate in case 1 and five other workers. Individuals sensitive to TMPTA and EA 1 resin in addition to urethane acrylate were also found. TMPTA allergy was not surprising as it had been reported previously. ' 23 Having identified urethane acrylate as the causal agent, chemical analysis was carried out to ascertain whether TDI, acrylic acid, or some other contaminant from the chemical synthesis present in the commercial material might be the true allergen, rather than urethane acrylate. No detectable isocyanate was found; this, combined with the negative patch test response to TDI, excluded it as the cause.
Unreacted acrylic acid could not be detected either, ruling it out as the cause. Accordingly, it was concluded that urethane acrylate was the source of the allergic contact dermatitis in the five workers with positive patch test reactions to urethane acrylate.
Two instances of positive epicutaneous tests to other acrylated chemicals were found in association with sensitivity to urethane acrylate. As cross reactivity between acrylates is uncommon,' ' Urethane acrylate may be a less potent allergen than TDI based on these findings in the guinea-pig, despite the fact that isocyanate monomers are well known but infrequently documented skin allergens. '2 20-22 Though urethane acrylate and TMPTA possessed equivalent allergenicity in the animal experiments, the lower apparent practical risk of sensitisation to TMPTA reflected in the relative incidence of cutaneous allergy to these two chemicals in this specific group of workers illustrates that animal studies, especially when one injects the chemical into the skin as in these experiments, may not correctly predict the practical risk of sensitisation in man or "predict the likelihood of sensitisation" in man-that is, risk.
The explanation for this disparity between the experimental and human experience with urethane acrylate and TMPTA may rest, in part, on the low irritancy of urethane acrylate, which has a Draize score of 075/8 compared with TMPTA which has a score of 5-2/8.'7 This relative lack of irritancy of urethane acrylate has probably resulted in greater skin contact as the inks containing it would not irritate the skin, and workers would be inclined to leave the ink on the skin for longer periods, thus increasing the chance of sensitisation. This hypothesis does not fully explain the difference, though. EA resins, such as EA 1, EA 2, and EA (b) have IDSC5O values much lower than urethane acrylate and lower irritancy based on their Draize scores. Despite this, they do not appear to sensitise appreciable numbers of those exposed to inks containing them. 6 The explanation may rest in solubility differences that may affect cutaneous penetration, in turn altering the chance of penetration of the chemical into the skin and the chance of inducing allergy. The intradermal method of induction in the animal experiments circumvents this. In keeping with this, solubility differences definitely exist between EA resins and urethane acrylate wherein the former chemicals are not well solubilised in propylene glycol while the latter, as well as MFAs and MMA, are quite soluble.
Animal investigation can shed light on the relative ability of cutaneous contactants to induce allergy. Such information is useful when endeavouring to reduce the hazard of the use of chemicals known to sensitise. In such instances it may not be possible to use a material that is absolutely safe-that is, nonsensitising-but only relatively safe. Comparison of the sensitisation potential of potent allergens, taking intradermal induction concentration into consideration as illustrated in these experiments, may allow a more discriminating method of comparison or relative allergenicity than is provided by the standard grading system originally proposed by Magnusson and Kligman. '4 The problem illustrated in this clinical situation with respect to such predictive laboratory tests is that the model considers relative sensitisation potential only within the confines of clearly defined, artificial conditions. Extrapolation to working conditions may have to take other factors into consideration, of which penetration through intact skin and likely exposure time in use are two. It is clear from the differences evident between the animal experiments and working circumstances with TMPTA, EA, and urethane acrylate that such predictions are complex.
Urethane acrylate resin is a cutaneous allergen that ranks comparably with PETA in its ability to cause allergic contact dermatitis when used in printing inks. The substitution of urethane acrylate for PETA offers no great health advantage. Both chemicals are relatively more hazardous than TMPTA, HDODA, or EA resin in this particular use.
